In the global pharmaceutical market, reliable sourcing of high-quality APIs and intermediates is critical. Aminophylline, known by its CAS number 317-34-0, is a versatile compound with significant therapeutic value, primarily in treating respiratory and cardiac conditions. NINGBO INNO PHARMCHEM CO.,LTD. is a distinguished aminophylline supplier China, offering excellence in product quality and supply chain reliability.

The primary use of Aminophylline powder is as a bronchodilator for conditions like asthma and COPD. Its ability to relax airway smooth muscles is fundamental to improving breathing. For pharmaceutical companies aiming to develop effective treatments, the ability to buy high purity aminophylline is paramount. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its Aminophylline powder consistently meets stringent purity standards, often exceeding 99%, positioning it as a top-tier aminophylline powder API.

Beyond its respiratory applications, Aminophylline's diuretic properties also make it valuable in managing cardiac asthma and other fluid retention issues. This broad utility makes it a staple in the pharmaceutical industry. Manufacturers must consider not only the quality but also the aminophylline pharmaceutical intermediate price when selecting a supplier. NINGBO INNO PHARMCHEM CO.,LTD. provides cost-effective solutions without compromising on the integrity of the product.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a leading provider of aminophylline powder for respiratory use and other medical applications. Our robust quality control systems, including adherence to GMP and ISO standards, guarantee the safety and efficacy of our products. We understand that a consistent and reliable supply is crucial for our clients' manufacturing processes.

Choosing a partner like NINGBO INNO PHARMCHEM CO.,LTD. for your Aminophylline needs means securing a commitment to quality, competitive pricing, and dependable service. We aim to facilitate the development of essential medicines, contributing to better patient outcomes through the provision of superior pharmaceutical ingredients for treatments like aminophylline asthma treatment.